
@article{ref1,
title="Three-year outcome following moderate-to-severe  TBI in U.S. Military service members: a descriptive cross-sectional study",
journal="Military medicine",
year="2014",
author="Brickell, Tracey A. and Lange, Rael T. and French, Louis M.",
volume="179",
number="8",
pages="839-848",
abstract="This study examined the prospective course of neurobehavioral symptom reporting and health-related quality of life within the first 3 years following moderate-to-severe traumatic brain injury (TBI). Participants were 52 U.S. service members who were evaluated following a moderate-to-severe TBI sustained in the combat theater during Operations Iraqi and Enduring Freedom (90.4%), or from other noncombat-related incidents. Participants completed the Neurobehavioral Symptom Inventory and Post-Traumatic Stress Disorder-Checklist within 3 months postinjury, and at least one follow-up telephone interview at 12 (n = 27), 24 (n = 31), or 36 months (n = 22) postinjury. Approximately half of the sample (41.9%-63.0%) reported &quot;persistent&quot; symptoms from baseline to follow-up. A substantial minority also &quot;improved&quot; (22.2%-31.8%) or &quot;developed&quot; new symptoms (3.7%-16.1%). Ongoing physical and mental health problems were also reported. The number of service members receiving mental health treatment significantly reduced between 12 and 36 months postinjury (48.1%-18.2%), while complaints of bodily pain significantly increased (40.7%-68.2%). Despite ongoing symptom reporting, few reported suicidal/homicidal ideation (6.5%-9.1%), and a substantial majority reported good/excellent health status (74.1%-90.9%) and satisfaction with their life (81.5%-90.9%). Continued support and care for all service members who sustain a combat-related moderate-to-severe TBI is recommended, regardless of the presence or absence of symptom reporting within the first few months postinjury.<p/> <p>Language: en</p>",
language="en",
issn="0026-4075",
doi="10.7205/MILMED-D-14-00016",
url="http://dx.doi.org/10.7205/MILMED-D-14-00016"
}